
Volabay 0.3 Tablet
Marketer
Wallace Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Volabay 0.3 Tablet
Diabetol 0.3mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating elevated postprandial blood glucose. It's prescribed when dietary modifications and other comparable therapies prove insufficient to manage hyperglycemia. Diabetol 0.3mg should be administered immediately prior to meals. Dosage and frequency are determined by your physician to optimize glycemic control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, potentially leading to severe complications including renal impairment and visual disturbances. This medication forms part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial. Commonly reported adverse effects include abdominal distension, stomach discomfort, appetite reduction, bowel irregularity, and diarrhea. Report persistent or bothersome side effects to your physician. While Diabetol 0.3mg itself doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) may increase this risk. Hypoglycemic episodes require treatment with plain glucose; sucrose is ineffective in this context. Inform your physician of any hepatic or renal dysfunction prior to commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice before use. Disclose all medications currently being taken to ensure treatment safety. Limit alcohol consumption during treatment to minimize the risk of hypoglycemia.
Primary Ingredients of Volabay 0.3 Tablet
There is no text provided to rephrase.
Uses of Volabay 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Volabay 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Volabay 0.3 Tablet on an empty stomach.
Common Side effects of Volabay 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Volabay 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Volabay 0.3mg tablets should be taken on an empty stomach.
How Volabay 0.3 Tablet works:
Volabay 0.3mg tablets are used to manage diabetes. Their mechanism of action involves suppressing the intestinal enzymes that digest complex carbohydrates into simpler sugars like glucose, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Volabay 0.3 Tablet and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Volabay 0.3 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Volabay 0.3 Tablet while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Volabay 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Volabay 0.3 mg tablets cautiously; dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Volabay 0.3mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Volabay 0.3 Tablet :
Omit any missed Volabay 0.3 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Volabay 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
